Not based on current evidence
It is noteworthy that the volunteers included in this study had mild COVID-19 in 2021, prior to the emergence of the SARS-CoV-2 Omicron variant and when the Brazilian population had not completed the full COVID-19 vaccination schedule
It can also raise the risk of antibiotic resistance, where bacteria evolve to grow stronger and infections become more difficult to treat
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Peptides are typically administered via subcutaneous injection, but some are available as oral capsules, troches, or nasal sprays
When combined into a single vial, researchers get both peptides in one preparation